Literature DB >> 27645461

Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorder.

Stephen F Smagula1, Helmet T Karim2, Eric J Lenze3, Meryl A Butters1, Gregory F Wu4, Benoit H Mulsant5, Charles F Reynolds1,6, Howard J Aizenstein1,2.   

Abstract

OBJECTIVE: Eotaxin is a chemokine that exerts negative effects on neurogenesis. We recently showed that peripheral eotaxin levels correlate with both lower gray matter volume and poorer executive performance in older adults with major depressive disorder. These findings suggest that the relationship between eotaxin and set-shifting may be accounted for by lower gray matter volume in specific regions. Prior studies have identified specific gray matter regions that correlate with set-shifting performance, but have not examined whether these specific gray matter regions mediate the cross-sectional association between eotaxin and set-shifting.
METHOD: In 27 older adults (mean age: 68 ± 5.2 years) with major depressive disorder, we performed a whole brain (voxel-wise) analysis testing whether/where gray matter density statistically mediates the cross-sectional association of eotaxin and set-shifting performance.
RESULTS: We found the association between eotaxin and set-shifting performance was fully statistically mediated by lower gray matter density in left middle cingulate, right pre-/post-central, lingual, inferior/superior frontal, cuneus, and middle temporal regions.
CONCLUSION: The regions identified above may be both susceptible to a potential neurodegenerative effect of eotaxin, and critical to preserving set-shifting function. Longitudinal and intervention studies are needed to further evaluate whether targeting eotaxin levels will prevent neurodegeneration and executive impairment in older adults with depression.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  depression; eotaxin; executive function; geriatric; gray matter; immunology; magnetic resonance imaging (MRI); set-shifting

Mesh:

Substances:

Year:  2016        PMID: 27645461      PMCID: PMC5846473          DOI: 10.1002/gps.4585

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  24 in total

1.  Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods       Date:  2008-08

2.  Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra provides reduced effect of scanner for cortex volumetry with atlas-based method in healthy subjects.

Authors:  Masami Goto; Osamu Abe; Shigeki Aoki; Naoto Hayashi; Tosiaki Miyati; Hidemasa Takao; Takeshi Iwatsubo; Fumio Yamashita; Hiroshi Matsuda; Harushi Mori; Akira Kunimatsu; Kenji Ino; Keiichi Yano; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2013-04-26       Impact factor: 2.804

3.  Eotaxin levels and eosinophils in guinea pig broncho-alveolar lavage fluid are increased at the onset of a viral respiratory infection.

Authors:  J Scheerens; G Folkerts; H Van Der Linde; P J Sterk; D M Conroy; T J Williams; F P Nijkamp
Journal:  Clin Exp Allergy       Date:  1999-06       Impact factor: 5.018

4.  Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.

Authors:  Shriya H Kaneriya; Gregg A Robbins-Welty; Stephen F Smagula; Jordan F Karp; Meryl A Butters; Eric J Lenze; Benoit H Mulsant; Daniel Blumberger; Stewart J Anderson; Mary Amanda Dew; Francis Lotrich; Howard J Aizenstein; Breno S Diniz; Charles F Reynolds
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

5.  Are core component processes of executive function dissociable within the frontal lobes? Evidence from humans with focal prefrontal damage.

Authors:  Ami Tsuchida; Lesley K Fellows
Journal:  Cortex       Date:  2012-11-06       Impact factor: 4.027

6.  A detailed examination of cytokine abnormalities in Major Depressive Disorder.

Authors:  N M Simon; K McNamara; C W Chow; R S Maser; G I Papakostas; M H Pollack; A A Nierenberg; M Fava; K K Wong
Journal:  Eur Neuropsychopharmacol       Date:  2007-08-03       Impact factor: 4.600

Review 7.  Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.

Authors:  Breno S Diniz; Meryl A Butters; Steven M Albert; Mary Amanda Dew; Charles F Reynolds
Journal:  Br J Psychiatry       Date:  2013-05       Impact factor: 9.319

8.  Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults.

Authors:  Pedro V S Magalhaes; Karen Jansen; Laura Stertz; Pamela Ferrari; Ricardo Tavares Pinheiro; Ricardo A da Silva; Flávio Kapczinski
Journal:  J Psychiatr Res       Date:  2013-10-20       Impact factor: 4.791

9.  Correlating anterior insula gray matter volume changes in young people with clinical and neurocognitive outcomes: an MRI study.

Authors:  Sean N Hatton; Jim Lagopoulos; Daniel F Hermens; Sharon L Naismith; Maxwell R Bennett; Ian B Hickie
Journal:  BMC Psychiatry       Date:  2012-05-20       Impact factor: 3.630

Review 10.  Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.

Authors:  Michael J Stuart; Gaurav Singhal; Bernhard T Baune
Journal:  Front Cell Neurosci       Date:  2015-09-10       Impact factor: 5.505

View more
  2 in total

Review 1.  Disruption of Neural Homeostasis as a Model of Relapse and Recurrence in Late-Life Depression.

Authors:  Carmen Andreescu; Olusola Ajilore; Howard J Aizenstein; Kimberly Albert; Meryl A Butters; Bennett A Landman; Helmet T Karim; Robert Krafty; Warren D Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2019-08-07       Impact factor: 4.105

2.  Computational and experimental evaluation of the Tic-Tac-Toe RF coil for 7 Tesla MRI.

Authors:  Narayanan Krishnamurthy; Tales Santini; Sossena Wood; Junghwan Kim; Tiejun Zhao; Howard J Aizenstein; Tamer S Ibrahim
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.